Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab
Clinical trial NCT00946023 · TERMINATED
Trial details
- NCT number
- NCT00946023
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2013-07-01
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.